Anti-glomerular basement membrane disease during the COVID-19 pandemic

Kidney Int. 2020 Sep;98(3):780-781. doi: 10.1016/j.kint.2020.06.009. Epub 2020 Jun 26.

Authors

Maria Prendecki¹, Candice Clarke¹, Tom Cairns², Terry Cook¹, Candice Roufosse¹, David Thomas¹, Michelle Willicombe¹, Charles D Pusey³, Stephen P McAdoo⁴

Affiliations

¹ Centre for Inflammatory Disease, Imperial College London, London, UK; Renal Medicine, Imperial College Healthcare NHS Trust, London, UK.
² Renal Medicine, Imperial College Healthcare NHS Trust, London, UK.
³ Centre for Inflammatory Disease, Imperial College London, London, UK.
⁴ Centre for Inflammatory Disease, Imperial College London, London, UK; Renal Medicine, Imperial College Healthcare NHS Trust, London, UK. Electronic address: [email protected].

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adaptive Immunity
Adult
Aged
Anti-Glomerular Basement Membrane Disease / diagnosis
Anti-Glomerular Basement Membrane Disease / epidemiology*
Anti-Glomerular Basement Membrane Disease / immunology
Anti-Glomerular Basement Membrane Disease / virology
Antibodies, Viral / blood*
Antibodies, Viral / immunology
Betacoronavirus / genetics
Betacoronavirus / immunology*
Betacoronavirus / isolation & purification
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / epidemiology
Coronavirus Infections / immunology
Coronavirus Infections / virology
Female
Glomerular Basement Membrane / immunology
Glomerular Basement Membrane / pathology
Humans
Incidence
London / epidemiology
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / immunology
Pneumonia, Viral / virology
RNA, Viral / isolation & purification
SARS-CoV-2
Spike Glycoprotein, Coronavirus / immunology*

Substances

Antibodies, Viral
RNA, Viral
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2